160 related articles for article (PubMed ID: 3018803)
1. The role of beta-lactamase inhibitors in chemotherapy.
Neu HC
Pharmacol Ther; 1985; 30(1):1-18. PubMed ID: 3018803
[No Abstract] [Full Text] [Related]
2. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
Piddock LJ; Jin YF; Turner HL
J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
[TBL] [Abstract][Full Text] [Related]
3. Evolution of beta-lactamase inhibitors.
Rolinson GN
Rev Infect Dis; 1991; 13 Suppl 9():S727-32. PubMed ID: 1656513
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.
Easton CJ; Knowles JR
Antimicrob Agents Chemother; 1984 Sep; 26(3):358-63. PubMed ID: 6095753
[TBL] [Abstract][Full Text] [Related]
6. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
[TBL] [Abstract][Full Text] [Related]
7. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
Campos M; Alarcón MA; González H; Sánchez R
Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
[TBL] [Abstract][Full Text] [Related]
8. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
Brenner DG; Knowles JR
Biochemistry; 1984 Nov; 23(24):5839-46. PubMed ID: 6098300
[TBL] [Abstract][Full Text] [Related]
9. Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
Bolivar R; Weaver SS; Bodey GP
Diagn Microbiol Infect Dis; 1984 Jun; 2(3):255-60. PubMed ID: 6086213
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of cefodizime (HR-221) in combination with beta-lactamase inhibitors.
Segatore B; Perilli M; Franceschini N; Setacci D; Oratore A; Amicosante G
J Chemother; 1993 Jun; 5(3):147-50. PubMed ID: 8396624
[TBL] [Abstract][Full Text] [Related]
11. Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli.
Brenner DG; Knowles JR
Biochemistry; 1984 Nov; 23(24):5833-9. PubMed ID: 6098299
[TBL] [Abstract][Full Text] [Related]
12. New β-lactam antibiotics and β-lactamase inhibitors.
Bush K; Macielag MJ
Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactamase inactivation by mechanism-based reagents.
Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
[TBL] [Abstract][Full Text] [Related]
14. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
Sawai T; Tsukamoto K
J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
[TBL] [Abstract][Full Text] [Related]
15. [Beta-lactamase inhibitors].
Nishiya H; Kunii O
Nihon Rinsho; 1991 Sep; 49(9):2046-51. PubMed ID: 1960873
[No Abstract] [Full Text] [Related]
16. Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases.
Ohsuka S; Arakawa Y; Horii T; Ito H; Ohta M
Antimicrob Agents Chemother; 1995 Aug; 39(8):1856-8. PubMed ID: 7486932
[TBL] [Abstract][Full Text] [Related]
17. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Grace ME; Fu KP; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
[TBL] [Abstract][Full Text] [Related]
18. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
Moosdeen F; Keeble J; Williams JD
Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004
[TBL] [Abstract][Full Text] [Related]
19. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
Neu HC
Am J Med; 1985 Nov; 79(5B):2-12. PubMed ID: 3907341
[TBL] [Abstract][Full Text] [Related]
20. Penetration of beta-lactamase inhibitors into the periplasm of gram-negative bacteria.
Farmer TH; Degnan BA; Payne DJ
FEMS Microbiol Lett; 1999 Jul; 176(1):11-5. PubMed ID: 10418127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
